Data Foundry

Drug recalls 2014

Marcaine — Class I drug recall D-0002-2015

Terminated recall by Hospira Inc., reported 2014-10-08, distributed nationwide. Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particl

Recall numberD-0002-2015
Product typeDrug
ClassificationClass I
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmHospira Inc., Lake Forest, IL, United States
Recall initiated2014-06-17
Classified2014-10-01
Reported by FDA2014-10-08
Terminated2017-04-03
DistributedNationwide (US)
Quantity40,730 vials
Reason classesforeign material, specification failure
NDC00409-0525, 00409-0525-01, 00409-0525-25, 00409-1250, 00409-1250-01, 00409-1250-25, 00409-1530, 00409-1530-01, 00409-1530-25, 00409-1559, 00409-1559-10, 00409-1559-18, 00409-1559-19, 00409-1559-30, 00409-1560, 00409-1560-10, 00409-1560-18, 00409-1560-19, 00409-1560-29, 00409-1582, 00409-1582-10, 00409-1582-18, 00409-1582-19, 00409-1582-29, 00409-1587 and 32 more
Lot numbers09/15, 33-545-DD

Product

Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (150 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 NDC 0409-1560-29

Reason for recall

Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0002-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.